Skip to content

BioSig Technologies, Inc. STEX Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

CNB Financial logo
CNB FinancialCCNE
$0
Helen Of Troy logo
Helen Of TroyHELE
$20.8M-7.6%
Bioventus logo
BioventusBVS
$6M+33.4%
Ryan Specialty Holdings logo
Ryan Specialty HoldingsRYAN
$223.55M+9.5%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$19.87-29.9%
GitLab logo
GitLabGTLB
$700K-95.8%

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-56.4%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s share-based payment - unrecognized cost of nonvested awards?
BioSig Technologies, Inc. (STEX) reported share-based payment - unrecognized cost of nonvested awards of $0 in Q1 2026.
How has BioSig Technologies, Inc.'s share-based payment - unrecognized cost of nonvested awards changed year-over-year?
BioSig Technologies, Inc.'s share-based payment - unrecognized cost of nonvested awards decreased by 100.0% year-over-year, from $384.44K to $0.
What does share-based payment - unrecognized cost of nonvested awards mean?
This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.